Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 1
1988 1
1989 1
1990 1
1991 1
1992 3
1994 1
1996 2
1997 5
1998 3
1999 4
2000 8
2001 4
2002 3
2003 7
2004 2
2005 2
2006 6
2007 3
2008 2
2009 3
2010 2
2011 4
2012 4
2013 5
2014 2
2015 1
2016 3
2017 3
2018 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21976530

85 results

Results by year

Filters applied: . Clear all
Page 1
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
Palmedo H, Manka-Waluch A, Albers P, Schmidt-Wolf IG, Reinhardt M, Ezziddin S, Joe A, Roedel R, Fimmers R, Knapp FF Jr, Guhlke S, Biersack HJ. Palmedo H, et al. J Clin Oncol. 2003 Aug 1;21(15):2869-75. doi: 10.1200/JCO.2003.12.060. J Clin Oncol. 2003. PMID: 12885803 Clinical Trial.
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.
Han SH, de Klerk JM, Tan S, van het Schip AD, Derksen BH, van Dijk A, Kruitwagen CL, Blijham GH, van Rijk PP, Zonnenberg BA. Han SH, et al. J Nucl Med. 2002 Sep;43(9):1150-6. J Nucl Med. 2002. PMID: 12215552 Free article. Clinical Trial.
85 results